Tag: KRAS Inhibitor

Investment

BridgeBio Oncology Secures $200M for Cancer Drug Trials

May 2, 2024

BridgeBio Pharma has successfully raised $200 million to finance a new venture dedicated to oncology, ...

Ready to talk?

Fill out the contact form to get a free consultation

info@briolink.com

Menu

Follow Us